We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01449071
Recruitment Status : Completed
First Posted : October 7, 2011
Last Update Posted : February 12, 2014
Sponsor:
Information provided by (Responsible Party):
UCB Pharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2013
  Study Completion Date : March 2013
  Certification or Request for Extension to Delay Results Submission: January 16, 2014